SCHEMBL9770689

SCHEMBL9770689

Cc1ccc2c(c1)C(C)(C)CC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.41
ALDH1A1 P00352 2/20 0.41
ADRA2A P08913 1/20 0.39
KDM1A O60341 1/20 0.38
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2C19 P33261 1/20 0.36
PARP1 P09874 1/20 0.35
PARP10 Q53GL7 1/20 0.35
THRB P10828 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
TP53 P04637 1/20 0.34
ALOX15 P16050 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HTR5A P47898 1/20 0.34
MEN1 O00255 2/20 0.34
HTT P42858 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30695369 1.00 CYP3A4 (0.41) CYP3A4ALDH1A1ADRA2AKDM1AHTR2A
SCHEMBL31106547 0.88 RXRA (0.44) CYP3A4ALDH1A1KDM1AHTR2AHTR2C
SCHEMBL5646023 0.88 RXRA (0.44) CYP3A4ALDH1A1KDM1AHTR2AHTR2C
SCHEMBL5763435 0.85 CYP3A4 (0.50) CYP3A4ALDH1A1ADRA2AKDM1APARP1
SCHEMBL29959514 0.85 CYP3A4 (0.50) CYP3A4ALDH1A1ADRA2AKDM1APARP1
SCHEMBL17571344 0.79 CYP3A4 (0.39) CYP3A4ALDH1A1ADRA2AKDM1ACYP1A2
SCHEMBL17571339 0.79 CYP3A4 (0.39) CYP3A4ALDH1A1ADRA2AKDM1ACYP1A2
SCHEMBL12856786 0.79 CYP3A4 (0.39) CYP3A4ALDH1A1ADRA2AKDM1ACYP1A2
SCHEMBL22589962 0.79 ESR1 (0.35) CYP3A4ALDH1A1ADRA2AKDM1AHTR2A
SCHEMBL1615553 0.77 RXRA (0.46) CYP3A4ALDH1A1CYP1A2CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382910-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED 2023-11-30 US disclosed
EP-3362428-B1 NOVEL OCTAHYDROINDENYL PROPANAL COMPOUNDS INT FLAVORS & FRAGRANCES INC (US) 2020-05-06 EP disclosed
US-20180297922-A1 NOVEL OCTAHYDROINDENYL PROPANAL COMPOUNDS INT FLAVORS & FRAGRANCES INC (US) 2018-10-18 US disclosed
EP-3362428-A1 NOVEL OCTAHYDROINDENYL PROPANAL COMPOUNDS International Flavors & Fragrances Inc. (US) 2018-08-22 EP disclosed
CN-108290812-A Novel octahydro indenyl propionic aldehyde compound 国际香料和香精公司 2018-07-17 CN disclosed
WO-2017066214-A1 NOVEL OCTAHYDROINDENYL PROPANAL COMPOUNDS INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2017-04-20 WO disclosed
US-4987261-A Diaminoindane derivatives MITSUI TOATSU CHEMICALS, INC. (JP) 1991-01-22 US disclosed
US-4532357-A Reacting methylindanes with oxygen or air in presence of transition metal oxidation catalyst, recovering product by fractional distillation INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1985-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180297922-A1 NOVEL OCTAHYDROINDENYL PROPANAL COMPOUNDS OR51E2, CUTA, POLR1C CYP3A4 554/4885ALDH1A1 152/4885ADRA2A 2991/4885
US-20230382910-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN TRPV1, SCN3A, KCNN3 CYP3A4 685/4885ALDH1A1 1762/4885ADRA2A 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.